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Some models of brain energy metabolism used to inter-
pret in vivo 13C nuclear magnetic resonance spectro-
scopic data assume that intramitochondrial -keto-
glutarate is in rapid isotopic equilibrium with total brain
glutamate, most of which is cytosolic. If so, the kinetics
of changes in 13C-glutamate can be used to predict citric
acid cycle ﬂux. For this to be a valid assumption, the
brain mitochondrial transporters of glutamate and
-ketoglutarate must operate under physiologic condi-
tions at rates much faster than that of the citric acid
cycle. To test the assumption, we incubated brain mito-
chondria under physiologic conditions, metabolizing
both pyruvate and glutamate and measured rates of
glutamate, aspartate, and -ketoglutarate transport. Un-
der the conditions employed (66% of maximal O2 con-
sumption), the rate of synthesis of intramitochondrial
-ketoglutarate was 142 nmol/minmg and the combined
initial rate of -ketoglutarate plus glutamate efﬂux from
the mitochondria was 95 nmol/minmg. It thus seems that
much of the -ketoglutarate synthesized within the mi-
tochondria proceeds around the citric acid cycle without
equilibrating with cytosolic glutamate. Unless the two
pools are in such rapid exchange that they maintain the
same percent 13C enrichment at all points, 13C enrich-
ment of glutamate alone cannot be used to determine
tricarboxylic acid cycle ﬂux. The -ketoglutarate pool is
far smaller than the glutamate pool and will therefore
approach steady state faster than will glutamate at the
metabolite transport rates measured.
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A long-standing goal of neurochemists has been to
establish noninvasive techniques to monitor O2 consumption
and citric acid cycle ﬂux in the whole brain (Aureli et al.,
1997; Dienel and Hertz, 2001; Gruetter et al., 2001). With
the advent of functional nuclear magnetic resonance (NMR)
imaging of the brain that maps areas activated by speciﬁc
intellectual tasks, the problem has become even more inter-
esting (Ugurbil et al., 2000; Lee and Chang, 2004). Func-
tional imaging is possible because of local changes in NMR
proton relaxation times in activated brain areas (Ogawa et al.,
1998). These proton changes may be due to changes in blood
ﬂow, increased O2 uptake, or increased glycolysis, but if O2
uptake could be monitored speciﬁcally in a spatially resolved
way, one could test these possibilities. Likewise, if reliable
methods for assessing citric acid cycle ﬂux become available,
pathologic conditions could be monitored and areas of neu-
rodegeneration identiﬁed.
Some years ago an innovative method was proposed for
noninvasively measuring brain glucose oxidation and citric
acid cycle ﬂux (Sibson et al., 1997). Although this method has
been used in a number of studies (Sibson et al., 1998, 2001),
it is criticized by others (Gruetter et al., 2001; Henry et al.,
2002, 2003; Xu et al., 2004). The technique employs 13C
NMR spectroscopy and monitors the carbon 4 of glutamate
labeled with 13C as [1-13C]glucose is infused into humans or
animals. The 2, 3, and 4 carbons of glutamate can be easily
monitored kinetically by 13C NMR spectroscopic tech-
niques. The carbon 4 of glutamate is labeled by
[1-13C]glucose in the ﬁrst turn of the citric acid cycle but
not in subsequent turns. The measurement of the kinetics
of [4-13C]glutamate appearance in the brain thus provides
an unambiguous measure of whole brain glutamate turn-
over. The assumption is then made that glutamate is in rapid
equilibrium with -ketoglutarate and changes in [4-14C]
enrichment in glutamate reﬂect those in [4-13C]-
ketoglutarate. This assumption is supported by the high
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activity of mitochondrial and cytosolic aspartate amino-
transferases. A potential ﬂaw in the assumption is that the
glutamate monitored is mostly cytosolic whereas the
-ketoglutarate, which reﬂects ﬂux through the citric acid
cycle, is inside the mitochondrial matrix space. Mitochon-
drial transport of -ketoglutarate or glutamate (Vx) across
the mitochondrial inner membrane would have to be an
order of magnitude faster than citric acid cycle ﬂux (VTCA)
to validate the assumption that the 13C enrichment in the
C-4 of glutamate is always equal to the 13C enrichment of
mitochondrial [4-13C]-ketoglutarate.
Various tests of the hypothesis have involved examina-
tion of the kinetics of appearance of 13C in [2,3-13C] of
glutamate and of aspartate (Mason et al., 1995; Sibson et al.,
1998; Gruetter et al., 2001; Henry et al., 2002). If the
assumption is correct, there would have to be a precursor/
product relationship between [4-13C]glutamate and [2-13C]
glutamate that appears only in the second turn of the cycle.
Some of these analyses have supported the hypotheses (Ma-
son et al., 1992, 1995); others have not (Gruetter et al., 2001).
Strangely, despite the fairly vigorous controversy, the rate of
transport of glutamate and -ketoglutarate into and out of
isolated brain mitochondria has not been monitored under
physiologic conditions.
The present study was undertaken to estimate ﬂux
through -ketoglutarate and glutamate transporters while
isolated brain mitochondria were oxidizing pyruvate and
glutamate under physiologic conditions. We measured citric
acid cycle ﬂux directly using measurements of O2 consump-
tion and rates of pyruvate and glutamate consumption when
both were present in the incubation medium.
Transport of -ketoglutarate and glutamate into and
out of the mitochondria was estimated simultaneously. O2
consumption was set at 66% of its maximal rate. Maximal
rates were determined in medium with saturating ADP
concentrations (5 mM). Rates of respiration below max-
imal were established with the aid of a hexokinase/ATP
trapping system. The initial concentration of ADP was
low (0.1 mM) but the ADP was regenerated with the
enzyme hexokinase plus its substrate glucose. Hexokinase
phosphorylates glucose to glucose-6-phosphate converting
ATP to ADP, and varying hexokinase varies respiration
rates. The incubation contained a physiologic concen-
tration of bicarbonate and free Ca2 was buffered at
0.244 M using an EGTA/Ca2 buffer (Patton et al.,
2004). The results of the investigation show that under the
conditions used, which were designed to maximize the
transport rates, -ketoglutarate and glutamate transport are
of the same order of magnitude as citric acid cycle ﬂux, not
an order of magnitude faster as suggested by other workers
(Mason et al., 1995). The results are discussed in light of
new discoveries about the distribution of the aspartate/
glutamate mitochondrial carrier in the brain.
MATERIALS AND METHODS
Isolation of Rat Brain Mitochondria
For isolating brain mitochondria, a modiﬁcation of the
method of Rosenthal et al. (1987) was used, which is one of two
methods currently in use. The other method (Clark and Nicklas,
1970)generatessynaptosomal-freemitochondria.Toisolatesynap-
tosomal-free mitochondria, crude mitochondria are passed
through a Ficoll gradient to separate synaptosomes from mito-
chondria. On the other hand, the method of Rosenthal et al.
(1987) breaks the synaptosomal membrane using a low concen-
tration of digitonin, which releases the synaptosomal mitochon-
dria from the synaptosomes. The protease Nagase is also used to
break up actin and intermediate ﬁlaments.
In our hands, yields from the Rosenthal method
(Rosenthal et al., 1987) are about twice as high as that from the
Ficoll method (Clark and Nicklas, 1970) (5–6 mg/rat brain)
and the respiratory control ratios are higher as well. The
Rosenthal method thus seems to provide a more representative
sample of total brain mitochondria (neuronal plus glial).
After anesthetizing 300–400 g male Sprague-Dawley rats,
we removed the skull and extracted the whole brain. The cortex
was separated from the rest of the brain, minced and washed free
of blood with buffer containing 225 mM mannitol, 75 mM
sucrose, 5 mM HEPES (pH 7.2), 1 mM EGTA, 1 mg/ml
bovine serum albumin (BSA) and then the brain was homoge-
nized in the same buffer with 0.5 mg/ml Nagase added and pH
adjusted to 7.3. Homogenate was diluted in buffer containing
mannitol, sucrose, and HEPES in the same concentrations as
above and mitochondria isolated by differential centrifugation.
Digitonin was included in the ﬁrst high-speed centrifugation but
not subsequent ones.
Incubations
Mitochondria were incubated in a buffer containing (in
mM): KCl 110; HEPES 20; MgCl2 5; KH2PO4 5; KHCO3 25;
glucose 5; ADP 0.1; CaCl2 0.6; EGTA 1; glutamate 5; and
pyruvate 1. Hexokinase was added to a ﬁnal concentration of
2 U/ml. The buffer was equilibrated with 95% O2/5% CO2 and
pH adjusted to 7.3.
Malate concentration was 0.5 or 5 mM. Free Ca2was set at
0.244Musing the computer programMaxChelator (Patton et al.,
2004) to determine the inﬂuence of EGTA/Ca2 ratios on free
calcium in our speciﬁc medium. Temperature was maintained at
37°C. Ca2 was set at this concentration because -ketoglutarate
dehydrogenase has a ka for free Ca
2 of 0.15 M (Wan et al.,
1989).
Some incubations included [U-14C]glutamate with a spe-
ciﬁc activity of 500 dpm/nmol whereas other incubations
contained [2-14C]pyruvate at3,000 dpm/nmol when measur-
ing 14C-metablites or 500 dpm/nmol when measuring 14CO2
production. All incubations included either 5 or 0.5 mM malate.
The reactions were initiated with 0.5–0.8 mg mitochon-
drial protein. Samples were taken at 0, 2, 4, 6, 8, and 10 min.
Protein was precipitated with perchloric acid (ﬁnal concentra-
tion 2%). Total speciﬁc activity in the neutralized, protein-free
ﬁltrates were determined by scintillation counting. 14C-Meta-
bolites were separated by ion exchange chromatography using
Dowex-1 acetate columns as described previously (Gamberino
et al., 1997). Mass amounts of -ketoglutarate, aspartate,
glucose-6-phosphate, glutamate, and pyruvate were determined
enzymatically (Bergmeyer, 1965; Williamson and Corkey,
1969), and protein was measured using the Bio-Rad reagent.
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When [2-14C]pyruvate was used as the labeled substrate,
parallel incubations were run to measure production of 14CO2.
Mitochondria were added to vials containing 1 ml of medium
preequilibrated with 95% O2/5% CO2. The vials were sealed
with rubber stoppers with a trap (a plastic well containing a
ﬂuted square of ﬁlter paper) attached. Mitochondria were incu-
bated for 2, 5, or 8 min. At the end of the designated time,
100 l of 1 N NaOH was injected into the ﬁlter paper trap and
100 l 20% perchloric acid was injected into the incubation
medium. The vials were shaken at room temperature for 2 hr
and then 14C in the ﬁlter paper trap was measured by liquid
scintillation counting.
O2 consumption was measured polarographically at 37°C
in separate incubations using a closed vessel with a Clark elec-
trode.
Methods of Calculation
Figure 1 shows the citric acid cycle, highlighting reactions
that produce 2 e/molecule. The electrons move through the
electron transport chain toward cytochrome oxidase, which uses
the electrons to reduce oxygen to H2O. The relevant move-
ments of metabolites (glutamate and -ketoglutarate) across the
mitochondrial membrane are also shown in Figure 1. The
-ketoglutarate carrier catalyzes exchange of malate for
-ketoglutarate. There are two functional glutamate carriers;
one catalyzes a unidirectional exchange of protonated glutamate
for aspartate and another catalyzes the exchange of glutamate for
a hydroxyl ion as illustrated (Palmieri, 2004). The labeled carbon
atom of pyruvate is indicated in Figure 1 as an open circle.
Figure 1 shows that this carbon will likely be trapped in the large
malate pool of the standard media.
Calculations of ﬂuxes through the various steps are made
assuming that certain relationships hold. Symbols have the fol-
lowing meaning:
● O2/t, rate of O2 consumption (natoms O/min  mg
protein)
● A, pyruvate dehydrogenase ﬂux (nmol pyruvate oxi-
dized/min  mg protein)
● B, isocitrate dehydrogenase ﬂux (nmol isocitrate oxi-
dized/min  mg protein)
● C, -ketoglutarate dehydrogenase ﬂux (nmol -keto-
glutarate oxidized/min  mg protein)
● D, succinate dehydrogenase ﬂux (nmol succinate oxi-
dized/min  mg protein)
● E, malate dehydrogenase (nmol malate oxidized/
min  mg protein)
●  asp/t, rate of appearance of aspartate in the me-
dium
●  [U-14C]glu/t, rate of disappearance of [U-14C]-
glutamate from the medium when [U-14C]glutamate is
initial substrate
● KG/t, rate of appearance of -ketoglutarate in
the medium
● 14C glu/t, rate of appearance of 14C-glutamate in
the medium when [2-14C]pyruvate is the initial sub-
strate.
We then assume:
● O2/t  A  B  C  D  E,
● A  rate of disappearance of pyruvate mass and 14C in
the [2-14C]pyruvate experiments,
● B  A,
● C AKG/t[U-14C]Glu/t14Cglu/t
(rate of pyruvate dehydrogenase minus efﬂux of
-ketoglutarate mass plus the rate of disappearance of
[U-14C]glu and minus the efﬂux of 14C-glutamate
when [2-14C]pyruvate is the labeled substrate),
● D  C, and
● E  A  asp/t (the conversion of malate to ox-
aloacetate is necessary for transamination of glutamate
to aspartate).
One can estimate citric acid cycle ﬂux either by measuring
O2/t (oxygen consumption) directly and estimating ﬂux
through the individual dehydrogenase reactions, or by measur-
ing each step as described above and comparing the sum of the
ﬂuxes generating 2e with the rate of O2 consumption. In this
study, the two methods agree within about 20%.
The appearance of -ketoglutarate in the medium is linear
for at least 6 min. This initial rate of -ketoglutarate efﬂux from
the mitochondria provides the value of KG/t. The percent
changes in glutamate mass were small, but efﬂux of 14C-
glutamate from the mitochondria could be measured in the
14C-pyruvate protocol (14C-glu/t) and inﬂux of 14C-
glutamate in the 14C-glutamate protocol [U-14C]glu/t. From
Fig. 1. Citric acid cycle including selected mitochondrial metabolite
transporters. Anaplerosis is not included in the diagram. The carbon
atoms of citric acid cycle intermediate oxaloacetate are given the
symbols X, whereas pyruvate carbons are designated with either ﬁlled
or open circles. The 14C-labeled carbon in the 2 position of pyruvate
is given the open circle. The carbons of the metabolites are shown to
retain these symbols as they are metabolized. The transporters are
designated OGC for the oxoglutarate carrier (malate/-ketoglutarate
exchanger), GH for the glutamate/hydroxyl carrier, and AGC for the
aspartate/glutamate carrier. The diagram illustrates the fact that the
labeled carbon [2-14C] of the pyruvate is not lost as 14CO2 in the ﬁrst
turn of the citric acid cycle.
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these data and the necessary calculations it is possible to compare
-ketoglutarate and glutamate transport with citric acid cycle
ﬂux.
RESULTS
Glutamate Transport
Glutamate transport (inward) was assessed in the
incubations with [U-14C]glutamate. Mass of glutamate in
each sample was measured at each time point with 5 or
0.5 mM malate, but the percent disappearance of gluta-
mate mass was too slow to measure accurately. The dis-
appearance of radiolabeled glutamate was measured in
those protocols that included [U-14C]glutamate and was
rapid enough to obtain an estimate. Moreover, we were
able to obtain an estimate of glutamate efﬂux from the
mitochondria when [2-14C]pyruvate was the initial sub-
strate, because the glutamate produced was labeled with
14C. The data are illustrated in Figure 2.
-Ketoglutarate Transport
The appearance of -ketoglutarate mass in the me-
dium as a function of time in the various incubations is
shown in Figure 3. The initial linearity of the efﬂux
suggests that initial rates represent a unidirectional outward
transport process. After 5–6 min, some -ketoglutarate
begins to return to the mitochondrial matrix especially in
the incubations with 0.5 mM as opposed to 5 mM malate.
There was no statistically signiﬁcant difference in the
appearance of -ketoglutarate mass comparing protocols
that contained [U-14C]glutamate as opposed to [2-14C]-
pyruvate.
Efﬂux rates are faster at higher levels of malate me-
dium because -ketoglutarate efﬂux is catalyzed by an
exchange carrier that transports -ketoglutarate in ex-
change for malate (Palmieri, 2004). We have determined
previously that the Km of malate for the -ketoglutarate/
malate exchange in rat heart mitochondria (LaNoue et al.,
1973) is 0.36  0.07 mM.
Citric Acid Cycle Flux
If pyruvate were the only substrate, one could easily
calculate citric acid cycle ﬂux from O2 consumption alone
or from the consumption of pyruvate because all electron-
producing steps (dehydrogenases) would produce elec-
trons at an equal rate. The presence of glutamate as an
additional substrate provides some complications. Oxygen
consumption was measured in separate incubations in the
presence of 5 or 0.5 mM malate. Because we used a
hexokinase trap to set O2 consumption at an intermediate
level, we ﬁrst determined the rate of O2 consumption
with excess ADP (maximum) and then the rate of O2
consumption with a limiting amount of hexokinase
(2 U/ml).
The O2 consumption under the experimental con-
ditions used in this study was 66% of maximal (Table I).
Rates of O2 consumption were not affected signiﬁcantly
by the malate concentration used in the incubations. The
data used to calculate ﬂuxes through the citric acid cycle
are shown in Tables II and III.
Table II provides the 14C data as a function of time.
These values were obtained by separating metabolites gen-
erated during the incubations by ion exchange chroma-
tography. The Dowex acetate column routinely used in
our laboratory (Lieth et al., 2001) separates glutamate,
aspartate, and lactate but the citric acid cycle intermediates,
citrate, succinate, -ketoglutarate, fumarate, and malate
remain on the column and are not eluted. Before running
the columns, the [2-14C]pyruvate in the samples was con-
verted to lactate so that the disappearance of [2-14C]-
radiolabeled pyruvate could be followed (Fig 4). Separate
experiments were designed to measure 14CO2 (Fig 4).
Because of the position of the 14C label on the carbon-2
atom of pyruvate, very little accumulated as 14CO2. In-
stead, it was trapped as 14C-malate in the large malate pool
(see Fig. 1) after one turn of the cycle.
The data of Table III were obtained by measuring
metabolite masses as a function of time. The pyruvate mass
and the disappearance of [2-14C]pyruvate provided similar
values for pyruvate disappearance. When changes in
[U-14C]glutamate were followed, the rate of [U-14C]-
glutamate disappearance was found to be faster than that of
glutamate mass (Fig. 2). In addition, a very signiﬁcant rate
of appearance of [5-14C]glutamate from [2-14C]pyruvate
was measured. Using these data for the appearance and
Fig. 2. The inﬂuence of time and medium concentrations of malate on
14C-glutamate levels in suspensions of brain mitochondria in physio-
logic medium. The circles represent [U-14C]glutamate disappearance in
medium, which includes 5 mM [U-14C]glutamate and 1 mM (unla-
beled) pyruvate. The triangles represent [5-14C]glutamate appearing in
medium that includes unlabeled 5 mM glutamate and 1 mM
[2-14C]pyruvate. The open symbols represent medium with 0.5 mM
malate and closed symbols represent medium with 5 mM malate. As
shown, the scales are different for glutamate disappearance (left-hand
scale) and appearance (right-hand scale). Values shown are means 
SEM. Data are reported in Table II as rates that were determined by
linear regression analysis of the curves shown here.
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disappearance of glutamate and the disappearance of
[2-14C]pyruvate (Table II and III) it was possible to cal-
culate ﬂux through the different steps of the citric acid
cycle as described above. Results of the calculations are
provided in Table IV. The dehydrogenase steps are not all
equal because of inﬂux of glutamate and malate, as well as
initial rates of -ketoglutarate efﬂux.
DISCUSSION
The studies reported provide initial rates of metab-
olite transport out of the mitochondria. The data therefore
cannot be extrapolated directly to the in vivo situation in
the intact brain because a steady state is maintained for
most metabolites in vivo. In this study, the system ap-
proaches a quasi-steady state as -ketoglutarate efﬂux de-
creases after 6–8 min. This is because the increased levels
of extramitochondrial -ketoglutarate stimulate inward
transport.
In the intact brain, however, the rate of -keto-
glutarate efﬂux is probably similar to that observed here,
especially at the more physiologic level of malate
(0.5 mM). To achieve steady state in the intact brain, some
of the cytosolic -ketoglutarate is transaminated to cyto-
solic glutamate via the cytosolic aspartate aminotransferase
and some is probably transported directly back into mito-
chondria. In this study, glutamate mass decreased because
Fig. 3. The inﬂuence of time and malate concentration
on the appearance of -ketoglutarate mass in suspensions
of brain mitochondria metabolizing glutamate plus pyru-
vate. A: Increases in -ketoglutarate mass in the presence
of 0.5 mM malate. B: Increases in -ketoglutarate mass in
the presence of 5 mM malate. Values shown are means
SEM (n  4). Rates of change are provided in Table III
and were obtained by linear regression analysis of the data
of Figure 3.
Fig. 4. The inﬂuence of time and malate concentration on disappear-
ance of [2-14C]pyruvate and appearance of 14CO2 in a suspension of
brain mitochondria in physiologic medium. The circles represent
[2-14C]pyruvate levels and the triangles 14CO2 in medium that initially
included 1 mM [2-14C]pyruvate and 5 mM unlabeled glutamate. Open
symbols represent medium with 0.5 mM malate and closed symbols
represent medium with 5 mM malate. As shown, the scales are different
for [2-14C]pyruvate (left-hand scale) and 14CO2 (right-hand scale).
Rates are reported in Table II and were determined by linear regression
analyses.
TABLE I. Respiration Rates of Brain Mitochondria*
Conditions 0.5 mM Malate 5 mM Malate
A 713  35 728  30
B 485  20 464  14
*Values given are natoms O/min  mg mitochondrial protein (means 
SEM). Mitochondria (0.5 mg/ml) were incubated at 37°C in the standard
buffer with either (A) 5 mM ADP to maximally stimulate respiration or (B)
2 units of hexokinase with 5 mM glucose to generate ADP at a slow,
constant rate.
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of the absence of cytosolic (medium) transamination;
however the glutamate itself can in theory enter and leave
the mitochondria. There are two glutamate transporters in
brain mitochondria (del Arco and Satrustegui, 1998;
Palmieri et al., 2001; Palmieri, 2004). One is the unidi-
rectional aspartate/glutamate carrier that is expressed as
two isoforms, only one of which (Aralar1) is expressed
abundantly in brain (Palmieri et al., 2001; Palmieri, 2004).
Exchange of glutamate for aspartate is stimulated by Ca2
and is electrogenic (del Arco and Satrustegui, 1998; La-
Noue et al., 1974; LaNoue and Tischler, 1974). Because it
is driven by the mitochondrial electrical potential, it can
only proceed in one direction, glutamate in and aspartate
out; therefore, without resynthesis from cytosolic -keto-
glutarate, cytosolic glutamate would decline. There is,
however, another glutamate transporter in the brain, the
glutamate/hydroxyl carrier, and it can run in reverse.
Inﬂux on this transporter is required to provide substrate
for glutamate dehydrogenase (Fig. 1) and its reversal is
probably responsible for the active efﬂux of glutamate
observed in the present experiments and for the very slow
decline of glutamate mass.
The data presented indicate that the -ketoglutarate/
malate exchanger and the glutamate/hydroxyl carrier cat-
alyze only a partial isotopic exchange with mitochondrial
-ketoglutarate. To estimate the extent of this exchange,
the rate of synthesis of intramitochondrial -ketoglutarate
was compared to the rate that -ketoglutarate and gluta-
mate are exported from the mitochondria.
We estimate that about 66% of the -ketoglutarate
synthesized is exported. The rate of synthesis of -keto-
glutarate can be estimated as the rate of glutamate entry
plus the rate of isocitrate dehydrogenase. At 0.5 mM
malate, net glutamate entry is 56 15 nmol/min  mg and
isocitrate dehydrogenase ﬂux is 86  4 nmol/min  mg.
The sum is 142 nmol/min  mg. That value can be
compared to initial rates of efﬂux of -ketoglutarate (44
3 nmol/min  mg) plus glutamate (50.9  0.9 nmol/
min  mg). The sum is 95 nmol/min  mg or 67% of the
rate that -ketoglutarate is synthesized within the mito-
chondria. It thus seems that about 33% of the mitochon-
drial -ketoglutarate could proceed around the citric acid
cycle without equilibrating with cytosolic glutamate. Sim-
ilar conclusions can be drawn when 5 mM malate is in the
medium.
The data indicate that the use of the kinetics of
[4-14C]glutamate turnover alone in the in vivo brain to
estimate citric acid cycle ﬂux underestimates the value. It
is possible, as shown by some authors (Gruetter et al.,
2001; Henry et al., 2002), to obtain more accurate values
for VTCA by including in the analysis values for glutamate
isotopomers generated in the second turn of the citric acid
cycle as well as isotopomers of aspartate. Studies similar to
those described here have been carried out with rabbit
heart mitochondrial (Lewandowski et al., 1997) and di-
rectly compared to measurements of citric acid cycle ﬂux
TABLE II. Rates of Change of Radiolabeled Metabolites in Incubations of Brain Mitochondria
Under Physiologic Conditions With 1 mM Pyruvate and 5 mM Glutamate†
Parameter measured
Initial 14C substrate
[2-14C]Pyr [U-14C]Glu
0.5 mM Malate 5 mM Malate 0.5 mM Malate 5 mM Malate
[U-14C]Glu disappearance — — 56.2  15 54.6  21
[5-14C]Glu 50.9  0.9* 31.9  1.2 — —
[2-14C]Pyr disappearance 86.5  4.2 83.0  6.0 — —
14C-Asp Negligible Negligible Negligible Negligible
†Values are given as nmol/min  mg protein (mean  SEM). Individual data points were obtained by dividing the
dpm in metabolite peaks by the speciﬁc activity of the metabolite or its precursor. Means of rates were obtained
by linear regression analysis of individual data points. Glu, glutamate; Pyr, pyruvate; Asp, aspartate.
*P 	 0.001 signiﬁcantly different from 5 mM.
TABLE III. Initial Rates of Change in Metabolites in Incubations
of Brain Mitochondria Under Physiologic Conditions
With 1 mM Pyruvate and 5 mM Glutamate†
Parameter 0.5 mM Malate 5 mM Malate
O2/t 485.0  20.0 464.0  14.0
Pyruvate 87.1  5.5 60.3  7.8
-Ketoglutarate 43.9  3.4* 67.4  4.9
Aspartate 24.8  2.0* 48.7  3.6
†Values shown are means  SEM (n  4). Details of conditions are
described in Methods. Except for O2/t, means of rates (nmol/min  mg)
were obtained by linear regression analyses of measured metabolite levels at
0, 2, 4, and 6 min.
*P 	 0.001 signiﬁcantly different from 5 mM.
TABLE IV. Summary of Calculations of Individual
Dehydrogenase Fluxes*
Dehydrogenase
Rate (nmol/min  mg)
0.5 mM Malate 5 mM Malate
A. Pyruvate dehydrogenase 86.5 83.0
B. Isocitrate dehydrogenase 86.5 83.0
C. -Ketoglutarate dehydrogenase 48.1 38.3
D. Succinate dehydrogenase 48.1 38.3
E. Malate dehydrogenase 111.5 131.7
*Values were calculated as described in Methods.
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in intact perfused rabbit hearts perfused with 13C substrates
(Lewandowski et al., 1997; O’Donnell et al., 1998, 2004;
Grifﬁn et al., 2000). Glutamate dehydrogenase and the
glutamate/hydroxyl carrier are very active and function-
ally important in brain (Plaitakis and Zaganas, 2001; Zaga-
nas et al., 2001) but much less active in hearts, making the
analysis more complex in the brain than the heart. In the
intact hearts, the rates monitored by [4-13C]glutamate
correlate directly with expression of the mitochondrial
-ketoglutarate/malate exchanger (Grifﬁn et al., 2000)
and do not correlate with citric acid cycle ﬂux (Lewan-
dowski et al., 1997; O’Donnell et al., 1998, 2004). In most
13C NMR spectroscopic studies that focus on energy
metabolism, the citric acid cycle ﬂux is abbreviated as
VTCA and the metabolite efﬂux as Vx. The kinetic model
used to calculate ﬂuxes in the heart can be veriﬁed inde-
pendently by measuring VTCA (citric acid cycle ﬂux) in-
dependently by other techniques (such as O2 consumption
or substrate consumption). The cardiac data suggest that
Vx routinely is lower than VTCA (Lewandowski et al.,
1997; O’Donnell et al., 1998, 2004; Grifﬁn et al., 2000).
The situation is likely to be somewhat more com-
plicated in the brain because of the higher activity of the
glutamate/hydroxyl carrier and the activity of glutamate
dehydrogenase. The kinetics of [4-13C]glutamate turn-
over, however, may provide a useful way to monitor
glutamate transport across the mitochondrial membrane
and estimate the malate/aspartate shuttle.
The malate/aspartate shuttle is the most active and
most commonly used shuttle required to transfer reducing
equivalents from the cytosol to the mitochondria (Meijer,
2003). Reducing equivalents (i.e., NADH) are generated
in the cytosol by conversion of lactate to pyruvate via
cytosolic lactate dehydrogenase, and by conversion of
glucose to pyruvate via the glycolytic pathway.
Because NADH is impermeable to the mitochon-
drial membrane, a metabolite shuttle system is needed to
move the electrons from NADH into the mitochondria
where oxidative phosphorylation can generate 2.5 mole-
cules of ATP from the energy made available by transfer of
these electrons (2e/molecule NADH) down the electron
transfer chain.
The step in the malate/aspartate shuttle that actually
moves the electrons into the mitochondria is the exchange
of cytosolic malate for mitochondrial -ketoglutarate. The
malate picks up the electrons from NADH via cytosolic
malate dehydrogenase. The -ketoglutarate efﬂux from
mitochondria partially monitored in the intact brain via
the appearance of [4-13C]glutamate may thus provide an
estimate of the malate/aspartate shuttle.
Because glucose is the major oxidative substrate of
the brain whereas hearts instead prefer fatty acids as sub-
strates, it seems that the in vivo [4-13C]glutamate kinetics
in the brain may approximate ﬂux through the malate/
aspartate cycle, thereby monitoring glucose oxidation.
Glucose consumption generates 2 nmol of NADH in the
cytosol for each nmol of glucose. In the absence of oxygen
or the absence of an NADH shuttle, the product of
glucose metabolism is lactic acid; however, it has been
made clear recently that not all brain cells have a functional
malate/aspartate shuttle (Ramos et al., 2003). Another
transporter required for operation of the shuttle is the
aspartate/glutamate carrier. A recent careful study of the
expression of this carrier in brain (Ramos et al., 2003)
indicates that it is not expressed in brain astrocytes. Be-
cause astrocytes are known to export lactate as a major
product of glucose metabolism (Tsacopoulos and Magis-
tretti, 1996), the absence of an NADH shuttle in these
cells perhaps is not surprising. The brain -ketoglutarate
pool is 0.1% of the brain glutamate pool. The measure-
ments of -ketoglutarate and glutamate transport made as
part of this study indicate that the transporters catalyze
ﬂuxes similar to those of the citric acid cycle. If the speciﬁc
activity of glutamate and -ketoglutarate change at equal
rates, and if the source of label was only pyruvate dehy-
drogenase, the transporter ﬂux would have to be an order
of magnitude faster. This is clearly not the case. However,
estimates of VTCAmade by perfusing brains with [1-
13C]glucose
and measuring turnover of [4-13C]glutamate are clearly not
wrong by an order of magnitude as judged by comparison
with more complete models (Oz et al., 2004).
The reason for this may be that glucose is a major
oxidative substrate for the brain and glucose cannot be
oxidized without consumption of the cytosolic NADH
generated by glycolysis. This consumption involves move-
ment of 2e from NADH to malate and exchange of
intramitochondrial -ketoglutarate for malate, which is
then oxidized by malate dehydrogenase. From Table IV, it
is apparent that in our in vitro study malate dehydrogenase
ﬂux is faster than KG dehydrogenase by more than a
factor of two. If allowed to proceed to steady state with a
complete malate/aspartate cycle supporting glucose oxi-
dation, malate dehydrogenase would proceed at twice the
rate of the other citric acid cycle enzymes. Glutamate
would exchange with aspartate at the same rate as pyruvate
oxidation (from glucose). This would explain why gluta-
mate turnover in the brain provides a good estimate of
citric acid cycle ﬂux, but in other organs where citric acid
cycle ﬂux is not linked to glucose oxidation glutamate
turnover does not provide a reliable estimate.
ACKNOWLEDGMENTS
This work was supported by grants from National
Institutes of Health (NS38641 to S.M.H. and K.F.L. and
NS38672 to R.G.).
REFERENCES
Aureli T, Di Cocco ME, Calvani M, Conti F. 1997. The entry of
[1-13C]glucose into biochemical pathways reveals a complex compart-
mentation and metabolite trafﬁcking between glia and neurons: a study by
13C-NMR spectroscopy. Brain Res 765:218–227.
Bergmeyer HU. 1965. Methods of enzymatic analysis. New York: Aca-
demic Press.
Clark JB, Nicklas WJ. 1970. The metabolism of rat brain mitochondria.
Preparation and characterization. J Biol Chem 245:4724–4731.
del Arco A, Satrustegui J. 1998. Molecular cloning of Aralar, a new member
of the mitochondrial carrier superfamily that binds calcium and is present
in human muscle and brain. J Biol Chem 273:23327–23334.
112 Berkich et al.
Dienel GA, Hertz L. 2001. Glucose and lactate metabolism during brain
activation. J Neurosci Res 66:824–838.
Gamberino W, Berkich DA, Lynch CJ, Xu B, LaNoue KF. 1997. Role of
pyruvate carboxylase in facilitation of synthesis of glutamate and glu-
tamine in cultured astrocytes. J Neurochem 69:2312–2325.
Grifﬁn JL, O’Donnell JM, White LT, Hajjar RJ, Lewandowski ED. 2000.
Postnatal expression and activity of the mitochondrial 2-oxoglutarate-
malate carrier in intact hearts. Am J Physiol Cell Physiol 279:1704–1709.
Gruetter R, Seaquist ER, Ugurbil K. 2001. A mathematical model of
compartmentalized neurotransmitter metabolism in the human brain.
Am J Physiol Endocrinol Metab 281:100–112.
Henry PG, Crawford S, Oz G, Ugurbil K, Gruetter R. 2003. Glucose and
glial-neuronal metabolism in a-chloralose anesthetized rats measured by in
vivo 13C NMR spectroscopy. 11th Scientiﬁc Meeting of the International
Society for Magnetic Resonance in Medicine. Toronto, ON. p 1967.
Henry PG, Lebon V, Vaufrey F, Brouillet E, Hantraye P, Bloch G. 2002.
Decreased TCA cycle rate in the rat brain after acute 3-NP treatment
measured by in vivo 1H-[13C] NMR spectroscopy. J Neurochem 82:
857–866.
LaNoue KF, Meijer AJ, Brouwer A. 1974. Evidence for electrogenic
aspartate transport in rat liver mitochondria. Arch Biochem Biophys
161:544–550.
LaNoue KF, Tischler ME. 1974. Electrogenic characteristics of the mito-
chondrial glutamate-aspartate antiporter. J Biol Chem 249:7522–7528.
LaNoue KF, Walajtys EI, Williamson JR. 1973. Regulation of glutamate
metabolism and interactions with the citric acid cycle in rat heart mito-
chondria. J Biol Chem 248:7171–7183.
Lee WT, Chang C. 2004. Magnetic resonance imaging and spectroscopy in
assessing 3-nitropropionic acid-induced brain lesions: an animal model of
Huntington’s disease. Prog Neurobiol 72:87–110.
Lewandowski ED, Yu X, LaNoue KF, White LT, Doumen C, O’Donnell
JM. 1997. Altered metabolite exchange between subcellular compart-
ments in intact postischemic rabbit hearts. Circ Res 81:165–175.
Lieth E, LaNoue KF, Berkich DA, Xu B, Ratz M, Taylor C, Hutson SM.
2001. Nitrogen shuttling between neurons and glial cells during glutamate
synthesis. J Neurochem 76:1712–1723.
Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny
EJ. 1995. Simultaneous determination of the rates of the TCA cycle,
glucose utilization, alpha-ketoglutarate/glutamate exchange, and glu-
tamine synthesis in human brain by NMR. J Cereb Blood Flow Metab
15:12–25.
Mason GF, Rothman DL, Behar KL, Shulman RG. 1992. NMR deter-
mination of the TCA cycle rate and alpha-ketoglutarate/glutamate ex-
change rate in rat brain. J Cereb Blood Flow Metab 12:434–447.
Meijer AJ. 2003. Amino acids as regulators and components of nonprotei-
nogenic pathways. J Nutr 133(Suppl):2057–2062.
O’Donnell JM, Doumen C, LaNoue KF, White LT, Yu X, Alpert NM,
Lewandowski ED. 1998. Dehydrogenase regulation of metabolite oxida-
tion and efﬂux from mitochondria in intact hearts. Am J Physiol 274:
467–476.
O’Donnell JM, Kudej RK, LaNoue KF, Vatner SF, Lewandowski ED.
2004. Limited transfer of cytosolic NADH into mitochondria at high
cardiac workload. Am J Physiol Heart Circ Physiol 286:2237–2242.
Ogawa S, Menon RS, Kim SG, Ugurbil K. 1998. On the characteristics of
functional magnetic resonance imaging of the brain. Annu Rev Biophys
Biomol Struct 27:447–474.
Oz G, Berkich DA, Henry PG, Xu Y, LaNoue KF, Hutson SM, Grueter
R. 2004 Neurological metabolism in the awake rat brain: CO2 ﬁxation
increases with brain activity. J Neurosci (in press).
Palmieri F. 2004. The mitochondrial transporter family (SLC25): physio-
logical and pathological implications. Pﬂugers Arch 447:689–709.
Palmieri L, Pardo B, Lasorsa FM, del Arco A, Kobayashi K, Iijima M,
Runswick MJ, Walker JE, Saheki T, Satrustegui J, Palmieri F. 2001.
Citrin and aralar1 are Ca(2)-stimulated aspartate/glutamate transporters
in mitochondria. EMBO J 20:5060–5069.
Patton C, Thompson S, Epel D. 2004. Some precautions in using chelators
to buffer metals in biological solutions. Cell Calcium 35:427–431.
Plaitakis A, Zaganas I. 2001. Regulation of human glutamate dehydroge-
nases: implications for glutamate, ammonia and energy metabolism in
brain. J Neurosci Res 66:899–908.
Ramos M, del Arco A, Pardo B, Martinez-Serrano A, Martinez-Morales
JR, Kobayashi K, Yasuda T, Bogonez E, Bovolenta P, Saheki T, Satru-
stegui J. 2003. Developmental changes in the Ca2-regulated mitochon-
drial aspartate-glutamate carrier aralar1 in brain and prominent expression
in the spinal cord. Brain Res Dev Brain Res 143:33–46.
Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S. 1987. Cerebral
ischemia and reperfusion: prevention of brain mitochondrial injury by
lidoﬂazine. J Cereb Blood Flow Metab 7:752–758.
Sibson NR, Dhankhar A, Mason GF, Behar KL, Rothman DL, Shulman
RG. 1997. In vivo 13C NMR measurements of cerebral glutamine
synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci
USA 94:2699–2704.
Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman
RG. 1998. Stoichiometric coupling of brain glucose metabolism and
glutamatergic neuronal activity. Proc Natl Acad Sci USA 95:316–321.
Sibson NR, Mason GF, Shen J, Cline GW, Herskovits AZ, Wall JE, Behar
KL, Rothman DL, Shulman RG. 2001. In vivo (13)C NMR measure-
ment of neurotransmitter glutamate cycling, anaplerosis and TCA cycle
ﬂux in rat brain during. J Neurochem 76:975–989.
Tsacopoulos M, Magistretti PJ. 1996. Metabolic coupling between glia and
neurons. J Neurosci 16:877–885.
Ugurbil K, Adriany G, Andersen P, Chen W, Gruetter R, Hu X, Merkle
H, Kim DS, Kim SG, Strupp J, Zhu XH, Ogawa S. 2000. Magnetic
resonance studies of brain function and neurochemistry. Annu Rev
Biomed Eng 2:633–660.
Wan B, LaNoue KF, Cheung JY, Scaduto RC Jr. 1989. Regulation of
citric acid cycle by calcium. J Biol Chem 264:13430–13439.
Williamson JR, Corkey BE. 1969. Assays of intermediates of the citric acid
cycle and related compounds by ﬂuorometric enzyme methods. In: Lo-
wenstein JM, editor. Methods of enzymology. New York: Academic
Press. p 435–513.
Xu Y, Oz G, LaNoue KF, Keiger CJ, Berkich DA, Gruetter R, Hutson
SM. 2004. Whole brain glutamate metabolism evaluated by steady state
kinetics using a double isotope procedure, effects of gabapentin. J Neu-
rochem 90:1104–1116.
Zaganas I, Waagepetersen HS, Georgopoulos P, Sonnewald U, Plaitakis A,
Schousboe A. 2001. Differential expression of glutamate dehydrogenase
in cultured neurons and astrocytes from mouse cerebellum and cerebral
cortex. J Neurosci Res 66:909–913.
Mitochondrial Glutamate Transport 113
